Literature DB >> 19366

Explanation of the observation of pancreatic ribonuclease activity at pH 4.5.

J Bartholeyns, D Wang, P Blackburn, G Wilson, S Moore, W H Stein.   

Abstract

A recent conclusion that beef pancreas contained a molecular species of ribonuclease with intrinsically high activity at pH 4.5 has been found to be incorrect. The particular assay used in the earlier experiments gives anomalous results at acid pH in the presence of low concentrations of ions such as phosphate which was used during the fractionation. By turning to the more widely employed form of the perchloric acid precipitation assay, interference is avoided and the ribonuclease in beef pancreas is confirmed as consisting almost completely of the molecular species well-characterized as ribonuclease A. The clarification of the assay question permits a clear interpretation of the results of each step of the chromatographic purification procedure that led to the initial conclusion, including an artifact that arose when gel filtration was attempted with distilled water rather than with buffer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19366     DOI: 10.1111/j.1399-3011.1977.tb02792.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  4 in total

1.  Correction of the anomalous electrophoretic behavior of ribonuclease A.

Authors:  J M Thomas; M E Hodes
Journal:  Experientia       Date:  1981-05-15

2.  A novel fully human antitumor immunoRNase resistant to the RNase inhibitor.

Authors:  Gennaro Riccio; Chiara D'Avino; Ronald T Raines; Claudia De Lorenzo
Journal:  Protein Eng Des Sel       Date:  2012-12-11       Impact factor: 1.650

3.  A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours.

Authors:  M Borriello; P Laccetti; G Terrazzano; G D'Alessio; C De Lorenzo
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

4.  A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.

Authors:  Chiara D'Avino; Dario Palmieri; Ashley Braddom; Nicola Zanesi; Cindy James; Sara Cole; Francesco Salvatore; Carlo M Croce; Claudia De Lorenzo
Journal:  Oncotarget       Date:  2016-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.